ResMed ROE - Return on Equity 2010-2024 | RMD

ResMed return on equity for the quarter ending September 30, 2024 was 23.2.

  • ResMed average return on equity for 2023 was 22.82, a 5.74% increase from 2022.
  • ResMed average return on equity for 2022 was 24.21, a 39.7% decline from 2021.
  • ResMed average return on equity for 2021 was 17.33, a 34.65% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

ResMed ROE - Return on Equity 2010-2024 | RMD

  • ResMed average return on equity for 2023 was 22.82, a 5.74% increase from 2022.
  • ResMed average return on equity for 2022 was 24.21, a 39.7% decline from 2021.
  • ResMed average return on equity for 2021 was 17.33, a 34.65% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.